Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (120)
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,290
Price
$10.63
Total Value
$2.90M
Shares Held After
2,298,783
% of Holdings
11.9%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,291
Price
$10.63
Total Value
$2.90M
Shares Held After
4,937,026
% of Holdings
5.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
471
Price
$69.37
Total Value
$32.67K
Shares Held After
533,779
% of Holdings
0.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,390
Price
$68.74
Total Value
$233.03K
Shares Held After
533,308
% of Holdings
0.6%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$113.52
Total Value
$567.58K
Shares Held After
424,360
% of Holdings
1.2%
Inhibrx Biosciences, Inc. (INBX)
FORSYTH DOUGLAS — Director
Shares
2,500
Price
$114.65
Total Value
$286.62K
Shares Held After
227,064
% of Holdings
1.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
9,681
Price
$112.28
Total Value
$1.09M
Shares Held After
730,548
% of Holdings
1.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,219
Price
$111.88
Total Value
$136.38K
Shares Held After
720,867
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
500
Price
$108.23
Total Value
$54.12K
Shares Held After
719,648
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,100
Price
$107.12
Total Value
$117.84K
Shares Held After
719,148
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
6,605
Price
$100.64
Total Value
$664.72K
Shares Held After
718,048
% of Holdings
0.9%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
5,895
Price
$99.29
Total Value
$585.34K
Shares Held After
711,443
% of Holdings
0.8%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
2,073,558
% of Holdings
10.6%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
4,711,801
% of Holdings
4.7%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,100
Price
$68.98
Total Value
$144.86K
Shares Held After
529,918
% of Holdings
0.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
918
Price
$69.52
Total Value
$63.82K
Shares Held After
527,818
% of Holdings
0.2%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
18,378
Price
$3.67
Total Value
$67.45K
Shares Held After
11,242,531
% of Holdings
0.2%
Atara Biotherapeutics, Inc. (ATRA)
Cherry Brian N — Director
Shares
104,166
Price
$9.60
Total Value
$999.99K
Shares Held After
166,486
% of Holdings
62.6%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
900,000
Price
$1.78
Total Value
$1.60M
Shares Held After
6,524,151
% of Holdings
13.8%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.79
Total Value
$47.90K
Shares Held After
1,070,746
% of Holdings
0.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$1.09
Total Value
$872.00
Shares Held After
381,985
% of Holdings
0.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
27,000
Price
$9.47
Total Value
$255.74K
Shares Held After
827,000
% of Holdings
3.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
900
Price
$68.95
Total Value
$62.05K
Shares Held After
526,900
% of Holdings
0.2%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
187,704
Price
$1.80
Total Value
$337.59K
Shares Held After
5,624,151
% of Holdings
3.3%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
95,000
Price
$11.80
Total Value
$1.12M
Shares Held After
4,265,014
% of Holdings
2.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
783
Price
$69.52
Total Value
$54.43K
Shares Held After
526,000
% of Holdings
0.1%
AN2 Therapeutics, Inc. (ANTX)
FitzPatrick Margaret M — Director
Shares
2,098
Price
$5.53
Total Value
$11.60K
Shares Held After
10,708
% of Holdings
19.6%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
179,058
Price
$1.80
Total Value
$321.57K
Shares Held After
5,436,447
% of Holdings
3.3%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
525
Price
$12.62
Total Value
$6.63K
Shares Held After
525
% of Holdings
100.0%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
90,000
Price
$11.59
Total Value
$1.04M
Shares Held After
4,071,252
% of Holdings
2.2%
ALTERITY THERAPEUTICS LTD (ATHE)
Marks Peter Ashley — Director
Shares
47,620
Price
$0.50
Total Value
$23.81K
Shares Held After
191,340
% of Holdings
24.9%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
10,000
Price
$3.96
Total Value
$39.60K
Shares Held After
10,000
% of Holdings
100.0%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
403,571
Price
$1.79
Total Value
$722.59K
Shares Held After
5,257,389
% of Holdings
7.7%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
100,000
Price
$0.05
Total Value
$5.00K
Shares Held After
690,167
% of Holdings
14.5%
Quoin Pharmaceuticals, Ltd. (QNRX)
Carter Denise P. — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,709
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Myers Michael — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,713
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Lawlor Sally Bridget — Chief Financial Officer
Shares
10,244
Price
$4.88
Total Value
$49.99K
Shares Held After
10,684
% of Holdings
95.9%
Quoin Pharmaceuticals, Ltd. (QNRX)
Culverwell Anthony James — Director
Shares
6,146
Price
$4.88
Total Value
$29.99K
Shares Held After
40,364
% of Holdings
15.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
217
Price
$69.10
Total Value
$14.99K
Shares Held After
525,217
% of Holdings
0.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.23
Total Value
$341.18K
Shares Held After
525,000
% of Holdings
1.0%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
94,767
Price
$0.06
Total Value
$5.69K
Shares Held After
590,167
% of Holdings
16.1%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
46,620
Price
$1.35
Total Value
$62.94K
Shares Held After
735,701
% of Holdings
6.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.81
Total Value
$344.05K
Shares Held After
520,000
% of Holdings
1.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
20,113
Price
$68.42
Total Value
$1.38M
Shares Held After
515,000
% of Holdings
3.9%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
10,000
Price
$71.40
Total Value
$713.97K
Shares Held After
494,887
% of Holdings
2.0%
BIOVIE INC. (BIVI)
Chappell Amy Suzon — Director
Shares
727
Price
$2.16
Total Value
$1.57K
Shares Held After
727
% of Holdings
100.0%
BIOVIE INC. (BIVI)
KIM JOANNE WENDY — Chief Financial Officer
Shares
2,500
Price
$2.18
Total Value
$5.45K
Shares Held After
3,441
% of Holdings
72.7%
BIOVIE INC. (BIVI)
Palumbo Joseph M — Chief Medical Officer
Shares
4,843
Price
$2.16
Total Value
$10.46K
Shares Held After
6,036
% of Holdings
80.2%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
50,000
Price
$0.05
Total Value
$2.50K
Shares Held After
495,400
% of Holdings
10.1%
Showing 1–50 of 120 transactions (page 1 of 3)